Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-01-18 @ 6:34 PM
Study NCT ID:
NCT04522895
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2020-05-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IDH2-Post-Allo-Trial for Patients with IDH2-mut Myeloid Neoplasms After Allo-SCT
Sponsor:
Heinrich-Heine University, Duesseldorf
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AG-221CL-AML-PI13299
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None